| Literature DB >> 25599078 |
Elisabeth A B Berg1, JulieAnne G McGregor1, Madelyn E Burkart1, Caroline J Poulton1, Yichun Hu1, Ronald J Falk1, Susan L Hogan1.
Abstract
The use and impact of complementary and alternative medicine (CAM) for anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) has not been reported. AAV patients seeking care at our center inquired about CAM, prompting a formal study. Study objectives were to discern how many AAV patients used CAM and its perceived helpfulness in disease management.Entities:
Keywords: ANCA-Associated Vasculitis; Alternative Medicine; Autoimmune Disease; Complementary Medicine; Small Vessel Vasculitis
Year: 2014 PMID: 25599078 PMCID: PMC4295716 DOI: 10.12970/2310-9874.2014.02.03.2
Source DB: PubMed Journal: J Autoimmune Dis Rheumatol ISSN: 2310-9874
CAM Participant Description (n=107)
| DESCRIPTOR | n (%) or mean ± standard deviation; range |
|---|---|
| Sex (female) | 66 (62%) |
| Race (White) | 92 (86%) |
| Age years (mean) | 53 ± 17; 18 – 85 |
| Age at Diagnosis (range) | 46 ± 17; 11 – 85 |
| Years since diagnosis | 6.4± 5.8; 0–28 |
| Education: | |
| Some college or less | 57 (54%) |
| Graduated college | 30 (28%) |
| Post graduate-level schooling | 19 (18%) |
| Marital Status: | |
| Married/Live-in Partner/Widowed/Separated | 83 (78%) |
| Never Married | 17 (16%) |
| Divorced | 7 (7%) |
| Total Household Income (in US dollars) | |
| <=50,000 | 41 (43%) |
| >50,000 | 54 (57%) |
| Insurance: | |
| Private | 86 (80%) |
| Non-private | 21 (20%) |
| ANCA-associated vasculitis diagnosis: | |
| Microscopic polyangiitis (MPA) | 50 (47%) |
| Granulomatosis with polyangiitis (GPA) | 40 (38%) |
| Renal-limited | 14 (13%) |
| Eosinophilic granulomatosis with polyangiitis (EGPA) | 2 (2%) |
| ANCA Specificity: | |
| Proteinase 3 ANCA | 51 (48%) |
| Myeloperoxidase ANCA | 47 (44%) |
| ANCA Negative | 9 (8%) |
| Organ Involvement (not mutually exclusive): | |
| Kidney | 93 (87%) |
| Joints | 59 (55%) |
| Lung | 57 (53%) |
| Upper respiratory | 57 (53%) |
| Dermatological | 31 (29%) |
| Neurological | 22 (21%) |
| Muscular | 14 (13%) |
| Gastrointestinal | 6 (6%) |
Percents within subheadings represent those with available data with missing data noted as follows: Education n=1 (1%); Household income n=12 (11%); ANCA Diagnosis n=1.
Renal limited patients separated from Microscopic Polyangiitis patients due to differences in relapse rates
Reasons Participants Used CAM and Perceived Helpfulness (Participants Checked all that Applied)
| Visiting providers/receiving CAM | Reason for Using CAM | CAM Provider or Treatment Helpfulness | |||||
|---|---|---|---|---|---|---|---|
| n = 107 (%) | Acute | Long-Term | Improve | Very | Somewhat | None/Don’t know | |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Prayer | 68 (64) | 12 (18) | 35 (51) | 36 (53) | 46 (68) | 5 (7) | 7 (10) |
| Exercise promotion | 29 (27) | 1 (3) | 5 (17) | 25 (86) | 20 (69) | 8 (28) | 0 (0) |
| Massage therapist | 20 (19) | 2 (10) | 5 (25) | 14 (70) | 17 (85) | 2 (10) | 0 (0) |
| Chiropractor | 14 (13) | 11 (79) | 4 (29) | 5 (36) | 9 (64) | 4 (29) | 1 (7) |
| Acupuncturist | 7 (7) | 0 (0) | 6 (86) | 2 (20) | 1 (14) | 2 (29) | 4 (57) |
| Relaxation techniques | 22 (21) | 1 (5) | 8 (36) | 15 (68) | 13 (59) | 8 (36) | 0 (0) |
| Meditation | 14 (13) | 1 (7) | 4 (29) | 9 (64) | 9 (64) | 3 (21) | 0 (0) |
| Guided imagery | 5 (5) | 9 (0) | 4 (80) | 2 (40) | 3 (60) | 2 (40) | 0 (0) |
| Total Unique Mind | 30 (28) | 2 (7) | 16 (53) | 26 (87) | 25 (83) | 13 (43) | 0 (0) |
| Yoga | 13 (12) | 0 (0) | 4 (31) | 9 (69) | 11 (85) | 2 (15) | 0 (0) |
| Qigong | 2 (2) | 0 (0) | 1 (50) | 2 (100) | 1 (50) | 0 (0) | 0 (0) |
| Tai Chi | 2 (2) | 0 (0) | 1 (50) | 1 (50) | 2 (100) | 0 (0) | 0 (0) |
| Pilates | 1 (1) | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | 0 (0) |
| Total Unique individuals using Mind/Body-Based | 15 (14) | 0 (0) | 6 (40) | 13 (87) | 15 (100) | 2 (13) | 0 (0) |
| Mind OR Mind/Body-Based | 31 (29) | ||||||
Association Between CAM Practices
| CAM Type | Exercise | P-value | |
|---|---|---|---|
| No | Yes | ||
| 0.0006 | |||
| No | 73 (94%) | 19 (66%) | |
| Yes | 5 (6%) | 10 (34%) | |
| 0.0015 | |||
| No | 63 (81%) | 14 (48%) | |
| Yes | 15 (19%) | 15 (52%) | |
| 0.99 | |||
| No | 28 (36%) | 11 (39%) | |
| Yes | 50 (64%) | 18 (62%) | |
P values calculated by Fisher Exact test.
Descriptive Information of Patients Using Mind, Mind-Body, Mind or Mind-Body and Neither
| Mind | Mind-Body | Mind OR Mind-Body | Neither | ||||||
|---|---|---|---|---|---|---|---|---|---|
| p-value | n=30 | % | n=15 | % | n=31 | % | n=76 | % | |
| Age (mean) | 0.0016 | 44±18.36 | 43±15.57 | 45±18.21 | 56±15.23 | ||||
| Sex (female) | 0.8272 | 19 | 63% | 11 | 73% | 20 | 65% | 46 | 61% |
| Race (white) | 0.7610 | 25 | 83% | 12 | 80% | 26 | 84% | 66 | 87% |
| Yrs diagnosed (mean) | 0.1502 | 8.64±7.92 | 9.88±7.38 | 8.48±6.21 | 6.75±5.47 | ||||
| Some college or less | 12 | 41% | 4 | 27% | 12 | 40% | 45 | 59% | |
| College Grad/Post Grad | 17 | 57% | 11 | 73% | 18 | 58% | 31 | 41 | |
| <=50,000 | 18 | 62% | 7 | 50% | 18 | 60% | 23 | 35% | |
| >50,000 | 11 | 38% | 7 | 50% | 12 | 40% | 42 | 55% | |
| Missing | 1 | 1 | 1 | 11 | |||||
| Private | 25 | 83% | 13 | 87% | 26 | 84% | 60 | 79% | |
| Non-private | 5 | 17% | 2 | 13% | 5 | 16% | 16 | 21% | |
| Never Married | 11 | 37% | 7 | 47% | 11 | 35% | 6 | 8% | |
| Married/Live-in Partner/Widowed/Separated | 17 | 57% | 7 | 47% | 18 | 58% | 65 | 86% | |
| Divorced | 2 | 7% | 1 | 7% | 2 | 6% | 5 | 7% | |
| MPA | 13 | 43% | 11 | 73% | 13 | 42% | 37 | 49% | |
| GPA | 13 | 43% | 4 | 27% | 13 | 42% | 27 | 36% | |
| Renal-Limited | 3 | 10% | 4 | 27% | 4 | 13% | 10 | 13% | |
| eGPA | 1 | 3% | 0 | 0% | 1 | 3% | 1 | 1% | |
| Missing | 0 | 0% | 0 | 0% | 0 | 0% | 1 | 1% | |
| MPO | 13 | 43% | 9 | 60% | 14 | 45% | 33 | 43% | |
| PR3 | 15 | 50% | 5 | 33% | 15 | 48% | 36 | 47% | |
| Negative | 2 | 7% | 1 | 7% | 2 | 6% | 7 | 9% | |
| Lung | 0.6697 | 17 | 57% | 5 | 33% | 18 | 58% | 39 | 51% |
| Upper Resp | 0.3932 | 19 | 63% | 8 | 53% | 19 | 61% | 38 | 50% |
| Joints | 0.5213 | 19 | 63% | 7 | 47% | 19 | 61% | 40 | 53% |
| Neurological | 0.6013 | 5 | 17% | 4 | 27% | 5 | 16% | 17 | 22% |
| Derm | 0.6447 | 9 | 30% | 7 | 47% | 10 | 32% | 21 | 28% |
| Kidney | 0.7531 | 27 | 90% | 14 | 93% | 28 | 90% | 65 | 86% |
MPA = microscopic polyangiitis; GPA = granulomatosis with polyangiitis; eGPA = eosinophilic granulomatosis with polyangiitis; MPO = myeloperoxidase ANCA; PR3 = proteinase 3 ANCA.
p-value for Mind OR Mind-Body vs. Neither.
Data missing for one individual in Mind and Mind OR Mind-Body categories.
CAM Association Chart
| More likely to be/have: | Mind | Mind-Body | Mind or Mind-Body | Prayer | Exercise | Chiropractor | Acupuncture | Massage Therapy |
|---|---|---|---|---|---|---|---|---|
| Younger | ++ | ++ | ++ | 0 | + | 0 | 0 | ++ |
| Female | 0 | + | 0 | 0 | + | + | ++ | + |
| White | 0 | 0 | 0 | − − | 0 | 0 | 0 | 0 |
| Employed | + | ++ | + | 0 | + | 0 | − − | ++ |
| Graduated college | + | ++ | 0 | 0 | ++ | 0 | − | ++ |
| Income <$50,000 | ++ | − | ++ | ++ | − | 0 | 0 | − − |
| Private insurance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ++ |
| Never married | ++ | ++ | ++ | 0 | + | 0 | 0 | 0 |
| GPA | 0 | 0 | 0 | 0 | 0 | + | − − | − |
| PR3 | 0 | − | 0 | 0 | + | + | ++ | 0 |
| Diagnosed > 5 yrs | + | + | + | 0 | 0 | 0 | 0 | 0 |
| Diagnosed longer ago | + | + | + | 0 | + | + | 0 | + |
| Lung | 0 | − | 0 | 0 | 0 | 0 | + | 0 |
| Upper respiratory | + | 0 | + | + | 0 | 0 | + | 0 |
| Joints | + | 0 | 0 | − | 0 | + | 0 | + |
| Gastrointestinal | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Muscular | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Neurological | 0 | 0 | 0 | 0 | 0 | 0 | ++ | 0 |
| Dermatologic | 0 | + | 0 | 0 | 0 | 0 | ++ | + |
| Kidney | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0 = no association; + = 10–20% association; ++ = >20% association; − = 10–20% no association; − − = >20% no association; GPA = granulomatosis with polyangiitis; PR3 = proteinase 3.
Association was determined with P values calculated by Fisher Exact test for categorical variables and Wilcoxon two-sample test and Kruskal-Wallis test for continues variables in two or three groups.